Granules

Drug makers Lupin and Granules India have decided to recall close to 9.71 lakh bottles of generic diabetes drug in the US. They were forced to take this extreme step…

View Post

Latest News

Granules India Gets Tentative Nod From USFDA

February 13, 2020 21:00
Healthwire Bureau

New Delhi: Granules India on Thursday said the US health regulator has given its tentative approval to Guaifenesin extended-release tablets used as expectorant. “US Food & Drug Administration (USFDA) has…

View Post

Menu

Granules

Lupin, Granules India Recall 9.71 Lakh Bottles Of Diabetes Drug In The US Market

Granules India Gets Tentative Nod From USFDA

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial